/
TEVA
$36.69+$0.17 (+0.47%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$42.8B
1,165M shares
52-week range
$17.33 – $37.39
97% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NYSE
ADRC
Change+$26.95
Teva Pharmaceutical Industries Limited American Depositary Shares
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
www.tevapharm.com- Employees
- 32,842
- IPO / List date
- Feb 16, 1982
- HQ
- TEL AVIV
Held by traders on TradeandTell
No one on the platform currently holds TEVA.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Bridgewater Associatesas of 2026-03-31 | 1,128,406 | $34.0M |
| Renaissance Technologiesas of 2025-09-30 | 1,002,545 | $20.3M |
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2002-12-06 | 2-for-1 |
Recent trades on TradeandTell
No one on the platform has traded TEVA yet.
